Latest filing published 25 May 2016 for Stereotaxis, Inc..
No signal scores available.
Based on 6 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Eric N. Prystowsky has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Cardionet Inc, Stereotaxis, Inc. and Biotelemetry, Inc. In total, 40 filings cover trades dated from 5 March 2008 to 24 May 2016.
On the open market, the record shows 7 purchases worth €33k and 13 sales worth €1.2M. Sales outweigh purchases by €1.2M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 14 share grants and 3 option exercises.
In size, the median ticket on the buying side is €4,988. After 6 purchases with a full 90-day history, the hit rate stands at 100% and the median 90-day move at +36.8%. These figures describe past trades and do not predict future prices.
Most recently, on 25 May 2016, the filings show a share grant in Stereotaxis, Inc. The last insider purchase was made public on 19 May 2009, 6,367 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 39 declarations